Kura Oncology (KURA) Tops Q2 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.59), $0.04 better than the analyst estimate of ($0.63).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Morgan Stanley Downgrades Peloton Interactive (PTON) to Underweight
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight